RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Goldman Sachs Alternatives
G

Goldman Sachs Alternatives

Goldman Sachs Alternatives has backed 3 companies on Recent Funding, 2 in the last 12 months; its most recent deal is Cyera (2026-09-22).

TypeInvestor
Portfolio on Recent Funding3
Deals, last 12 months2
Rounds led1 of 3
Capital in their rounds$700M

What Goldman Sachs Alternatives invests in

How Goldman Sachs Alternatives invests

StageDealsCapital in rounds
Series b+ 3 100%$700M
YearDealsCapital in rounds
2024 1 33%$225M
2026 2 67%$475M

Share is of the 3 rounds on Recent Funding that name Goldman Sachs Alternatives. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio

CompanyRound with Goldman Sachs AlternativesTotal raisedLatest raise
CCyera
Cybersecurity
Series b+ · $400M · lead$2.7BSep 22, 2026
Series b+
RRedwood Materials
AI infrastructure and compute
Series b+ · $75M$2.67BJul 31, 2026
round
SSeaport Therapeutics
Health and bio
Series b+ · $225M$325MOct 21, 2024
Series b+

Most frequent co-investors

Portfolio companies are the companies on Recent Funding with a round that lists Goldman Sachs Alternatives, which is a subset of its real portfolio. API: /api/v1/investors/goldman-sachs-alternatives. All investors.

Catch them early

Stealth builders and new accelerator batches, weekly.

Unsubscribe anytime · privacy